Lumida
/SBRA
⌘K
Sabra Health Care REIT Inc

Sabra Health Care REIT Inc

SBRA
$20.11USD-0.25%-0.05 today

MARKET CAP

5.1B

P/E (TTM)

31.9x

FWD P/E

26.6x

DAY RANGE

$20 – $21

52W RANGE

$17
$21

AI Summary

Stalk
Sell NowMedium

The Stage 4 decline structure and active Support Failure pattern confirm a medium-term bearish bias. Despite extreme oversold conditions and a shallow relief bounce, price remains below all falling EMAs with no repair evident, indicating supply still dominates. Short-term positioning supports immediate sell-side engagement into the 9/21 EMA zone. We recommend a Sell Now posture to capture the downtrend resumption.

  • 14.4% YoY same-store managed senior housing NOI growth shows robust demand.
  • Q1 normalized FFO per share rose 9% YoY to $0.38, fueling distributions.
  • Negative earnings yield and weak profitability factors suggest value erosion.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Sabra Health Care REIT (NASDAQ:SBRA) is a leading real estate investment trust (REIT) that focuses on acquiring and managing healthcare-related properties, primarily skilled nursing facilities and senior housing. Situated within the healthcare sector, Sabra is poised to capitalize on demographic trends that favor senior living. The company is strategically positioned to leverage technology and innovation in managing healthcare assets while addressing challenges in staffing and regulatory impacts.

Bull says

  • 14.4% YoY same-store managed senior housing NOI growth shows robust demand.
  • Q1 normalized FFO per share rose 9% YoY to $0.38, fueling distributions.
  • $0.30 quarterly dividend covers 77% of AFFO, signaling payout sustainability.
  • Solid liquidity of $1.2 billion supports a $206 million YTD investment pipeline.
  • Strong dividend yield and low share volatility appeal to risk-averse investors.
  • Positive momentum and AI efficiency upside may not yet be priced in.

Bear says

  • Negative earnings yield and weak profitability factors suggest value erosion.
  • Analyst downward revisions point to weaker future earnings visibility.
  • High short interest reflects investor skepticism and potential share pressure.
  • 77% dividend payout ratio limits reinvestment and heightens coverage risk.
  • Rising private equity competition squeezes acquisition pricing and yields.
  • Medicaid/Medicare rate uncertainty threatens predictable revenue streams.

Investment themes with SBRA

Nuclear +1.23%

Nuclear energy production and related companies

WELL · PLD · EQIX
Demographics: Elderly Care -0.26%

Services and products for aging population

UCB.BR · JNJ · AZN
Residential REITs +0.00%

Stable income from diversified rental housing portfolios

WELL · PSA · VTR

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-01-2026bullish

Transcript signals

Bull points

  • For the first quarter of 2026, we recognized normalized FSO per share of $0.38, and normalized AFFO per share of $0.39, which represents a 9% and 5% increase, respectively, over the same period in 2025.
  • In absolute dollars, normalized FFO and normalized AFFO totaled $96.1 million and $100.6 million this quarter, respectively.
  • Cash and OI from our triple net portfolio increased $2.2 million from last quarter, primarily due to annual rent escalators and increased collections from certain cash basis tenants.
Read full transcript analysis ›